OTCMKTS:HPPI HedgePath Pharmaceuticals (HPPI) Stock Price, News & Analysis $0.06 +0.00 (+5.18%) As of 05/22/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About HedgePath Pharmaceuticals Stock (OTCMKTS:HPPI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get HPPI alerts:Sign Up Key Stats Today's Range$0.06▼$0.0650-Day Range$0.04▼$0.0752-Week Range$0.04▼$0.32Volume20,677 shsAverage Volume19,283 shsMarket Capitalization$21.82 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewHedgePath Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for patients with cancers and non-cancerous proliferation disorders in the United States. It primarily focuses on the development of therapies for skin, lung, and prostate cancers. The company's Hedgehog signaling pathway is a primary regulator of cellular processes in vertebrates, including stem cell maintenance, cell differentiation, tissue polarity, and cell proliferation. It also develops super bioavailability (SUBA)-itraconazole oral capsules for patients with basal cell carcinoma nevus syndrome. SUBA-Itraconazole is a patented itraconazole formulation that enhances the absorption of itraconazole to enhance the bioavailability of orally administered drugs that are poorly soluble. The company was founded in 1992 and is headquartered in Tampa, Florida. HedgePath Pharmaceuticals, Inc. is a subsidiary of Mayne Pharma Ventures Pty Ltd.Read More… Receive HPPI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HedgePath Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address HPPI Stock News HeadlinesEagle Pharmaceuticals Inc.February 17, 2024 | wsj.comSee More Headlines HPPI Stock Analysis - Frequently Asked Questions How have HPPI shares performed this year? HedgePath Pharmaceuticals' stock was trading at $0.0601 at the beginning of 2025. Since then, HPPI stock has decreased by 2.0% and is now trading at $0.0589. View the best growth stocks for 2025 here. How do I buy shares of HedgePath Pharmaceuticals? Shares of HPPI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of HedgePath Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that HedgePath Pharmaceuticals investors own include Mesoblast (MESO), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Coca-Cola (KO), MSP Recovery (LIFW), MSP Recovery (LIFW) and Marathon Oil (MRO). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Commercial Physical Research Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:HPPI CIK1042418 Webwww.hedgepathpharma.com Phone813-509-2417FaxN/AEmployees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,550,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-246.03% Debt Debt-to-Equity RatioN/A Current Ratio6.76 Quick Ratio6.76 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.01) per share Price / Book-5.89Miscellaneous Outstanding Shares370,446,000Free FloatN/AMarket Cap$21.82 million OptionableNot Optionable Beta-1.16 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (OTCMKTS:HPPI) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HedgePath Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share HedgePath Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.